SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-23-000428
Filing Date
2023-03-30
Accepted
2023-03-30 08:16:57
Documents
92
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20221231x10k.htm   iXBRL 10-K 4631901
2 EX-4.4 tmb-20221231xex4d4.htm EX-4.4 23716
3 EX-21.1 tmb-20221231xex21d1.htm EX-21.1 13357
4 EX-23.1 tmb-20221231xex23d1.htm EX-23.1 5362
5 EX-31.1 tmb-20221231xex31d1.htm EX-31.1 13668
6 EX-32.1 tmb-20221231xex32d1.htm EX-32.1 8654
7 GRAPHIC tmb-20221231x10k001.jpg GRAPHIC 46974
8 GRAPHIC tmb-20221231x10k002.jpg GRAPHIC 54975
  Complete submission text file 0001410578-23-000428.txt   21247411

Data Files

Seq Description Document Type Size
9 EX-101.SCH tmb-20221231.xsd EX-101.SCH 82321
10 EX-101.CAL tmb-20221231_cal.xml EX-101.CAL 71272
11 EX-101.DEF tmb-20221231_def.xml EX-101.DEF 454608
12 EX-101.LAB tmb-20221231_lab.xml EX-101.LAB 598442
13 EX-101.PRE tmb-20221231_pre.xml EX-101.PRE 650390
86 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221231x10k_htm.xml XML 5579290
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12584 | Film No.: 23777249
SIC: 2834 Pharmaceutical Preparations